Loading...

GALERA THERAPEUTICS INC Capital Structure Changes 8-K Filing

GLR

GALERA THERAPEUTICS INC

()

2026 8-K

Stock Increase Approved

Stockholder Meeting Results

Merger Announcement

Stock Conversion Completed

Annual Meeting Notice

Preferred Stock Amendment

Executive Bonus Agreement

Asset Sale Agreement

Asset Sale Agreement

Royalty Agreement Update

Agreement Amendment

Acquisition Completed

Director Elections

External Links:

On April 7, 2026, Galera Therapeutics converted 76,479.175 shares of Series B Preferred Stock into 76,479,164 shares of common stock. Additionally, on April 8, 2026, Ikarian Capital exercised warrants to purchase 8,488,229 shares of common stock for about $8,488.

AI Assistant

GALERA THERAPEUTICS INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.